Arafa O E, Geiran O R, Andersen K, Fosse E, Simonsen S, Svennevig J L
Department of Thoracic and Cardiovascular Surgery, Rikshospitalet, Oslo, Norway.
Ann Thorac Surg. 2000 Nov;70(5):1587-93. doi: 10.1016/s0003-4975(00)01864-6.
Right ventricular failure from elevated pulmonary vascular resistance in the recipient is a main cause of early mortality after heart transplantation. When pharmacologic treatment is insufficient, mechanical circulatory assistance has been used to support the failing right ventricle. Considering right and left ventricular interdependence, we investigated whether intraaortic balloon counterpulsation (IABP) might also alleviate predominantly right ventricular dysfunction after heart transplantation.
Among 278 cardiac recipients, 12 adult patients underwent mechanical circulatory support for cardiac allograft dysfunction. Five patients were treated with percutaneous IABP for early postoperative low cardiac output syndrome characterized by predominantly right ventricular failure. Clinical data and hemodynamic variables were recorded before and during IABP treatment.
Cardiac index (CI) and mean arterial pressure (MAP) increased (CI 1.7 +/- 0.1 to 2.5 +/- 0.2, MAP 53 +/- 12 to 71 +/- 7, p < 0.05) within 1 hour after IABP, whereas central venous pressure (CVP) and pulmonary artery wedge pressure (PAWP) decreased (CVP 21.6 +/- 1.7 to 13.8 +/- 3.1, p < .05; PAWP 14.8 +/- 4.9 to 12.4 +/- 3.7, nonsignificant). Within the next 12 hours, CI and mixed venous oxygen saturation increased (p < 0.05) and pulmonary artery pressure decreased (p < 0.05). All 5 patients were weaned successfully and 4 are long-term survivors with adequate cardiac performance at 1 year follow-up.
Intraaortic balloon pumping is a minimally invasive circulatory assist device with proved efficiency in low cardiac output syndromes. This report shows that low output syndrome caused by predominantly right ventricular allograft failure may be an additional indication for IABP.
受者肺血管阻力升高导致的右心室衰竭是心脏移植术后早期死亡的主要原因。当药物治疗不足时,已采用机械循环辅助来支持衰竭的右心室。考虑到左右心室的相互依存关系,我们研究了主动脉内球囊反搏(IABP)是否也能缓解心脏移植术后主要的右心室功能障碍。
在278例心脏移植受者中,12例成年患者接受了心脏移植功能障碍的机械循环支持。5例患者因术后早期以右心室衰竭为主的低心排血量综合征接受了经皮IABP治疗。记录IABP治疗前和治疗期间的临床数据和血流动力学变量。
IABP治疗后1小时内,心脏指数(CI)和平均动脉压(MAP)升高(CI从1.7±0.1升至2.5±0.2,MAP从53±12升至71±7,p<0.05),而中心静脉压(CVP)和肺动脉楔压(PAWP)降低(CVP从21.6±1.7降至13.8±3.1,p<0.05;PAWP从14.8±4.9降至12.4±3.7,无统计学意义)。在接下来的12小时内,CI和混合静脉血氧饱和度升高(p<0.05),肺动脉压降低(p<0.05)。所有5例患者均成功撤机,4例在1年随访时心脏功能良好,为长期存活者。
主动脉内球囊泵是一种微创循环辅助装置,在低心排血量综合征中已证明有效。本报告表明,主要由右心室移植失败引起的低排血量综合征可能是IABP的另一个适应证。